There has been much interest in inhibiting GSK-3β for the treatment of Alzheimer's disease, and other neurological disorders, due to its ability to phosphorylate the microtubule associated Tau protein [26], [27] as well as influence inflammation [28], [29], [30]. This evidence concerns the gene GSK3B and nervous system disorder.